$OBIO

Orchestra BioMed Holdings, Inc.

Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · New Hope, PA

OBIO chart

What traders are saying about $OBIO

Latest posts

Orchestra BioMed Holdings, Inc. news

Orchestra BioMed Holdings, Inc. key financials

USD2025202420232022
Revenue$33.5M$2.6M$2.8M$3.5M
Net income-$52.7M-$61.0M-$49.1M-$33.6M
Diluted EPS$-1.11$-1.66$-1.48$-2.24
Total assets (year end)$114.9M$76.2M$95.2M$95.6M
Cash and equivalents (year end)$34.7M$22.3M$30.6M$19.8M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Orchestra BioMed Holdings, Inc.

Ticker
OBIO (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
New Hope, PA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1814114
Former names
Health Sciences Acquisitions Corp 2

Frequently asked questions

What exchange is Orchestra BioMed Holdings, Inc. listed on?

Orchestra BioMed Holdings, Inc. trades on the Nasdaq under the ticker symbol OBIO.

What industry is Orchestra BioMed Holdings, Inc. in?

Orchestra BioMed Holdings, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.

Where is Orchestra BioMed Holdings, Inc. headquartered?

Orchestra BioMed Holdings, Inc.'s business address on file with the SEC is in New Hope, PA.

When does Orchestra BioMed Holdings, Inc.'s fiscal year end?

Orchestra BioMed Holdings, Inc.'s fiscal year ends on December 31.

How much revenue did Orchestra BioMed Holdings, Inc. report?

Orchestra BioMed Holdings, Inc. reported $33.5M in revenue for calendar year 2025, according to its SEC filings.